Smith Anglin Financial’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-860
Closed -$228K 227
2025
Q1
$228K Buy
860
+15
+2% +$4K 0.02% 184
2024
Q4
$214K Buy
845
+35
+4% +$9.43K 0.02% 195
2024
Q3
$229K Buy
810
+2
+0.2% +$556 0.02% 180
2024
Q2
$215K Hold
808
0.02% 178
2024
Q1
$219K Sell
808
-106
-12% -$27.8K 0.02% 176
2023
Q4
$229K Sell
914
-329
-26% -$77.9K 0.03% 156
2023
Q3
$292K Buy
1,243
+75
+6% +$18.3K 0.04% 132
2023
Q2
$286K Buy
1,168
+60
+5% +$14.6K 0.03% 136
2023
Q1
$264K Buy
1,108
+213
+24% +$51.3K 0.04% 134
2022
Q4
$222K Buy
+895
New +$217K 0.04% 130

Other funds holding VHT

Smith Anglin Financial's VHT Position: Q2 2025 in Review

Smith Anglin Financial sold out of Vanguard Health Care ETF (VHT) in Q2 2025, closing a stake of 860 shares — an estimated $228K sold.

Smith Anglin Financial first reported a position in VHT in Q4 2022 and held it in 10 quarters. The position peaked at $292K in Q3 2023. 1,018 funds tracked by Wall St. Rank hold VHT as of Q2 2025.

  • Smith Anglin Financial reported no remaining Vanguard Health Care ETF position as of Q2 2025 after selling out during the quarter.
  • Smith Anglin Financial sold 860 Vanguard Health Care ETF shares in Q2 2025, an estimated $228K.
  • Smith Anglin Financial first reported a position in Vanguard Health Care ETF in Q4 2022 and held it in 10 quarters.
  • Smith Anglin Financial's Vanguard Health Care ETF position peaked at $292K in Q3 2023.
  • 1,018 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2025.

Based on Smith Anglin Financial's 13F filing for Q2 2025, filed 17 Jul 2025.